… representing separate arms of breast cancer treatment, when combined, … for early-stage breast cancer. The investigators concluded … including distant recurrence, death, or local recurrence, and no … for treatment of early breast cancer: a randomised trial. …

… high-risk triple-negative breast cancer (TNBC), a study … the occurrence of invasive breast cancer, recurrence elsewhere in the body … benefit in preventing recurrence or improving survival … for early triple-negative breast cancer. JAMA. Published online …

… for women with metastatic breast cancer. Feeling isolated, Cooke … said. A biopsy confirmed breast cancer. Initially, her doctors … increasing her risk of recurrence and other cancers. Given … for breast cancer While no one can fully prevent breast cancer, …

… locally advanced or metastatic breast cancer, treatment with Itovebi … breast cancer accounts for approximately 70% of breast cancer … advanced or metastatic breast cancer whose disease progressed … or metastatic breast cancer following recurrence on or after …

… and the Director of Breast Cancer Research at Sarah … II and III early breast cancer (eBC), regardless of … 20-year risks of breast-cancer recurrence after stopping endocrine therapy … 20-year risks of breast-cancer recurrence after stopping endocrine therapy …

… in patients with advanced breast cancer. This novel treatment … type of breast cancer. The ABC-Pax (Advanced Breast Cancer – Paxalisib) … immunotherapy-resistant triple negative breast cancer. The clinical trial … drive the spread and recurrence of the disease …

… felt immense guilt for how breast cancer affected her marriage and her … she overcame it As a breast cancer surgeon, I made a terrible … two experiences, and a local recurrence in my left breast two … I felt guilty for what breast cancer had brought to my marriage …

… breast cancer, as detected by an FDA-approved test, following recurrence … advanced or metastatic breast cancer whose disease … breast cancer (INAVO123; NCT06790693). HR-positive breast cancer is … the most prevalent type of all breast cancers …

… or developed disease recurrence during or within … breast cancer subtype, accounting for approximately 70% of all breast cancers … new breast cancer settings. In HR-positive breast cancer, … negative breast cancer, an aggressive form of breast cancer, AstraZeneca …

… of HR-positive metastatic breast cancer and following progression, … or HER2-ultralow metastatic breast cancer following endocrine therapy.” … shift in how certain breast cancers can be treated.” … setting or developed disease recurrence during or within …